Skip to content
Abierto
Menu

Special notice

Illumina MiSeq i100 System or equal

NOI_OC-2026-132529

Food and Drug Administration, FDA Office of Acq Grant SVCS. Analytical Laboratory Instrument Manufacturing.

View on SAM.govMarkdown

Response deadline

March 26, 2026 at 2:30 PM EDT

Closed 175 days ago. Posted March 20, 2026. Scheduled to archive April 10, 2026.

Description

As published on SAM.gov.

NOTICE OF INTENT TO SOLE SOURCE Description This notice is issued for informational and market research purposes only and does not constitute a solicitation. The FDA intends to award a sole source Firm-Fixed-Price purchase order for one (1) Whole Genome Sequencing instrument. The Government is considering the Illumina MiSeq i100 System or equal product that meets all salient characteristics identified in the Statement of Work (SOW).

Offerors proposing equal products shall demonstrate how the proposed product meets each of the salient characteristics The instrument shall include a minimum one (1) year manufacturer’s warranty covering parts and labor. Response Instructions Interested parties shall submit capability statements demonstrating ability to meet requirements. Offerors proposing an equivalent must clearly demonstrate how requirements are met. Response Deadline March 26, 2026, at 2:30 PM ET Submission Contracting Officer:

Iris Johnson Email: Iris.Johnson1@fda.hhs.gov

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 20, 2026

    Special notice

    Due March 26, 2026 at 2:30 PM EDT. SAM.gov, notice 6e4695e321fa4175bd2e225d9d9fa972

Points of contact

Also open from this buyer